Appili Therapeutics Inc. announced the appointment of Rochelle Stenzler to serve on its Board of Directors. A pharmacist by training, Ms. Stenzler brings to Appili’s Board extensive experience as a senior operating executive in healthcare and other industries. In addition to her role as Board Chair with Spartan Bioscience, she has previously served as President & CEO of TouchLogic Corporation; President, International Operations of TLC Laser Eye Centers Inc.; President of Revlon Canada Inc.; and President & General Manager of Pharma Plus Drugmarts Ltd. Prior to this role, she served as Board Chair of Cynapsus Therapeutics Inc., until it was acquired for C $841M by Sunovion Pharmaceuticals Inc. in late 2016. In her prior work with TLC Laser Eye Centers Inc., Ms. Stenzler served as co-COO of the $300 million laser vision correction business, helping reposition the company during its rapidly expanding North American operations. In her tenure as President of Revlon Canada, she played a key role in the company’s uccessful restructuring and implementation of major cultural changes.